Mecit Kaplan

3.9k total citations
7 papers, 118 citations indexed

About

Mecit Kaplan is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Mecit Kaplan has authored 7 papers receiving a total of 118 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in Mecit Kaplan's work include CAR-T cell therapy research (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Mecit Kaplan is often cited by papers focused on CAR-T cell therapy research (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Mecit Kaplan collaborates with scholars based in United States and China. Mecit Kaplan's co-authors include William P. Weidanz, Dean D. Manning, Henri C. van der Heyde, M. Merle Elloso, Pinaki P. Banerjee, Katayoun Rezvani, Vandana Nandivada, Rafet Başar, Qingfang He and Yan Zhang and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Mecit Kaplan

7 papers receiving 115 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mecit Kaplan United States 5 64 48 29 21 20 7 118
Ganga Nath Jha India 6 37 0.6× 52 1.1× 16 0.6× 46 2.2× 8 0.4× 8 138
Marine Gil France 6 13 0.2× 58 1.2× 30 1.0× 22 1.0× 10 0.5× 13 108
Pamela Aranda Lopez Germany 8 94 1.5× 7 0.1× 18 0.6× 20 1.0× 13 0.7× 15 131
Nahum Smith United States 5 16 0.3× 59 1.2× 34 1.2× 24 1.1× 36 1.8× 9 126
Ruddy Montandon France 5 85 1.3× 16 0.3× 13 0.4× 16 0.8× 8 0.4× 7 112
Toshinori Moriguchi Japan 6 45 0.7× 10 0.2× 21 0.7× 24 1.1× 21 1.1× 7 109
Ikbel Naouar Tunisia 8 47 0.7× 61 1.3× 9 0.3× 21 1.0× 37 1.9× 10 131
Stefanie Porkert Austria 6 35 0.5× 17 0.4× 58 2.0× 16 0.8× 36 1.8× 13 136
Alicia Tay Singapore 4 150 2.3× 12 0.3× 39 1.3× 48 2.3× 3 0.1× 5 179
Maximilian Schmid Germany 6 91 1.4× 26 0.5× 5 0.2× 21 1.0× 4 0.2× 8 126

Countries citing papers authored by Mecit Kaplan

Since Specialization
Citations

This map shows the geographic impact of Mecit Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mecit Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mecit Kaplan more than expected).

Fields of papers citing papers by Mecit Kaplan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mecit Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mecit Kaplan. The network helps show where Mecit Kaplan may publish in the future.

Co-authorship network of co-authors of Mecit Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Mecit Kaplan. A scholar is included among the top collaborators of Mecit Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mecit Kaplan. Mecit Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rafei, Hind, Bijender Kumar, Mayra Shanley, et al.. (2023). Radiation Therapy Sensitizes Head-and-Neck Cancer Cells to Killing by Chimeric Antigen Receptor (CAR)-NK Cells Targeting CD70. International Journal of Radiation Oncology*Biology*Physics. 117(2). S167–S168. 1 indexed citations
2.
Thompson, Philip A., Xianli Jiang, Pinaki P. Banerjee, et al.. (2022). A phase two study of high dose blinatumomab in Richter’s syndrome. Leukemia. 36(9). 2228–2232. 20 indexed citations
3.
Nieto, Yago, Pinaki P. Banerjee, Indreshpal Kaur, et al.. (2022). Abstract CT003: Innate cell engager (ICE®) AFM13 combined with preactivated and expanded cord blood (CB)-derived NK cells for patients with refractory/relapsed CD30+ lymphoma. Cancer Research. 82(12_Supplement). CT003–CT003. 13 indexed citations
4.
Kebriaei, Partow, Pinaki P. Banerjee, Christina Ganesh, et al.. (2020). Blinatumomab Is Well Tolerated Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 26(3). S102–S103. 3 indexed citations
5.
Kebriaei, Partow, Pinaki P. Banerjee, Christina Ganesh, et al.. (2019). Blinatumomab Is Well Tolerated Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia. Blood. 134(Supplement_1). 1298–1298. 9 indexed citations
6.
Zhang, Yan, et al.. (2015). Metabolic Engineering and Comparative Performance Studies of Synechocystis sp. PCC 6803 Strains for Effective Utilization of Xylose. Frontiers in Microbiology. 6. 1484–1484. 9 indexed citations
7.
Heyde, Henri C. van der, et al.. (1995). Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria.. The Journal of Immunology. 154(8). 3985–3990. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026